Search results
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 3 days agoThis week, telehealth prescription company Hims & Hers launched an initiative to offer glucagon-like...
Many people quit new weight-loss drugs because of costs, side effects
UPI· 6 hours agoLouis. Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of...
Ozempic Patients Are Switching to These Less Expensive Weight-Loss Drugs — Best Life
Best Life· 20 hours agoOzempic has taken the pharmaceutical world by storm in the last year. The semaglutide injection is...
Ozempic keeps wowing: trial data show benefits for kidney disease
Nature· 13 hours agoSemaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for...
It's Time for Over-the-Counter Ozempic
Reason.com via Yahoo News· 2 days agoAffordability is a problem, though. Novo Nordisk markets semaglutide as Ozempic, Wegovy, and Rybelsus. Eli Lilly markets tirzepatide as Mounjaro...
...Alternative Weight-loss Medications That Cost Nearly 90 Percent Less, What to Know: Price, How It...
WWD via Yahoo Finance· 3 days agoBoth brands began offering weight-loss programs in December, though they didn’t sell medications...
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 4 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 18 hours agoThe demand for GLP-1 semaglutide far exceeds the current supply, leading to shortages. Africa Studio...
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs...
Fast Company Magazine· 3 days agoThe medications that Hims & Hers will make available will be compounded versions of those drugs,...
Hims & Hers Will Sell Wegovy-Like Weight Loss Drugs for $199
Gizmodo via Yahoo Finance· 4 days agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering...